India bans 16 drug combos including paracetamol mixes

Several antibiotic combos were banned: amoxicillin with serratiopeptidase, amoxicillin with cloxacillin, cefadroxyl with probenecid, and cefuroxime with serratiopeptidase. The list also includes dermatological products mixing aloe vera with vitamin E, jojoba oil, tea tree oil, and other ingredients.

The ministry has banned similar FDCs in previous years. This round follows the same scientific review process.

For drugmakers, the ban means pulling existing stock and halting production. Companies that relied on these combos for revenue face an immediate hit. The broader read-through: India's regulator is tightening scrutiny on combination drugs, a category that has long drawn criticism for adding ingredients without clear benefit.

Patients using these drugs should check with their doctor for alternatives. The banned list includes common painkiller mixes and antibiotic combos prescribed for routine infections.

The ministry did not name specific companies affected. The order targets the formulations themselves, not individual manufacturers.